BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elfil M, Bahbah EI, Attia MM, Eldokmak M, Koo BB. Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson's Disease. Mov Disord 2021;36:570-80. [PMID: 33296545 DOI: 10.1002/mds.28412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zhao L, Ding X, Cui X, Qi L, Chen Y. Obstructive sleep apnea and the risk of Alzheimer's disease and Parkinson disease: A Mendelian randomization study OSA, Alzheimer's disease and Parkinson disease. Sleep Med 2022;97:55-63. [PMID: 35724440 DOI: 10.1016/j.sleep.2022.06.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dijkstra F, de Volder I, Viaene M, Cras P, Crosiers D. Polysomnographic Predictors of Sleep, Motor, and Cognitive Dysfunction Progression in Parkinson's Disease. Curr Neurol Neurosci Rep 2022. [PMID: 35994190 DOI: 10.1007/s11910-022-01226-2] [Reference Citation Analysis]
3 Meira B, Fernandes M, Salavisa M, Saraiva M, Conceição L, Borbinha C, Ladeira F, Marto JP, Barbosa R, Mendonça M, Bugalho P. Obstructive Sleep Apnea and Other Vascular Risk factors' Impact on Non‐Motor Symptoms in Parkinson's Disease. Movement Disord Clin Pract. [DOI: 10.1002/mdc3.13504] [Reference Citation Analysis]
4 Suzuki K, Funakoshi K, Fujita H, Hirata K. The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study. Clin Neuropharmacol 2022;45:61-4. [PMID: 35579485 DOI: 10.1097/WNF.0000000000000501] [Reference Citation Analysis]
5 Dong WL, Zhong JH, Chen YQ, Xie JF, Qin YY, Xu JP, Cai NB, Li MF, Liu L, Wang HT. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models. Acta Pharmacol Sin 2021;42:1991-2003. [PMID: 34531546 DOI: 10.1038/s41401-021-00768-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chang CP, Wu KC, Lin CY, Chern Y. Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases. J Biomed Sci 2021;28:70. [PMID: 34635103 DOI: 10.1186/s12929-021-00766-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Moon S, Mohamed AMA, He Y, Dong W, Yaosen C, Yang Y. Extraction vs. Nonextraction on Soft-Tissue Profile Change in Patients with Malocclusion: A Systematic Review and Meta-Analysis. Biomed Res Int 2021;2021:7751516. [PMID: 34589550 DOI: 10.1155/2021/7751516] [Reference Citation Analysis]
8 Li S, Jia C, Li T, Le W. Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go. Neurosci Bull 2021. [PMID: 34313916 DOI: 10.1007/s12264-021-00749-x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Weihs A, Frenzel S, Grabe HJ. The Link Between Obstructive Sleep Apnoea and Neurodegeneration and Cognition. Curr Sleep Medicine Rep 2021;7:87-96. [DOI: 10.1007/s40675-021-00210-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mutti C, Rausa F, Parrino L. Sleep in Neurologic Disorders. Sleep Med Clin 2021;16:499-512. [PMID: 34325826 DOI: 10.1016/j.jsmc.2021.05.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Dijkstra F, Reyn N, de Bruyn B, van den Bossche K, de Volder I, Willemen M, Viaene M, Jo Leenders, Cras P, Crosiers D. REM sleep without atonia and nocturnal body position in prediagnostic Parkinson's disease. Sleep Med 2021;84:308-16. [PMID: 34217921 DOI: 10.1016/j.sleep.2021.06.011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Lee HM, Han KD, Suh JD, Cho JH. Uvulopalatopharyngoplasty may decrease the incidence of Parkinson's disease associated with obstructive sleep apnea. Sci Rep 2021;11:9608. [PMID: 33953319 DOI: 10.1038/s41598-021-89205-4] [Reference Citation Analysis]
13 Bahbah EI, Ghozy S, Attia MS, Negida A, Emran TB, Mitra S, Albadrani GM, Abdel-Daim MM, Uddin MS, Simal-Gandara J. Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent. Mar Drugs 2021;19:201. [PMID: 33916730 DOI: 10.3390/md19040201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]